Title of Invention | A PHARMACEUTICAL COMPOSITION OF A BOTULINUM TOXIN FOR ORAL |
---|---|
Abstract | Pharmaceutical compositions comprising a botulinum toxin and a carrier for oral administration to a patient the formulation itself exhibiting a gastric retention due to mucoadhesion, flotation, sedimentation, expansion, delayed gastric emptying " initiated by a pharmacological agent. |
Full Text |
---|
00673-kolnp-2005-description complete.pdf
00673-kolnp-2005-international publication.pdf
673-kolnp-2005-granted-abstract.pdf
673-kolnp-2005-granted-assignment.pdf
673-kolnp-2005-granted-claims.pdf
673-kolnp-2005-granted-correspondence.pdf
673-kolnp-2005-granted-description (complete).pdf
673-kolnp-2005-granted-examination report.pdf
673-kolnp-2005-granted-form 1.pdf
673-kolnp-2005-granted-form 18.pdf
673-kolnp-2005-granted-form 3.pdf
673-kolnp-2005-granted-form 5.pdf
673-kolnp-2005-granted-gpa.pdf
673-kolnp-2005-granted-letter patent.pdf
673-kolnp-2005-granted-reply to examination report.pdf
673-kolnp-2005-granted-specification.pdf
673-kolnp-2005-granted-translated copy of priority document.pdf
Patent Number | 220472 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Indian Patent Application Number | 00673/KOLNP/2005 | ||||||||
PG Journal Number | 22/2008 | ||||||||
Publication Date | 30-May-2008 | ||||||||
Grant Date | 28-May-2008 | ||||||||
Date of Filing | 19-Apr-2005 | ||||||||
Name of Patentee | ALLERGAN, INC | ||||||||
Applicant Address | 2525 DUPONT DRIVE, T2-7H, IRVINE, CA 92612 | ||||||||
Inventors:
|
|||||||||
PCT International Classification Number | A61K 35/74 | ||||||||
PCT International Application Number | PCT/US2003/034903 | ||||||||
PCT International Filing date | 2003-11-03 | ||||||||
PCT Conventions:
|